Induction of Immune-Stimulating Factors and Oncolysis Upon p14ARF Gene Transfer in Melanoma Cell Lines
- 1 June 2023
- journal article
- research article
- Published by Mary Ann Liebert Inc in DNA and Cell Biology
- Vol. 42 (6), 274-288
- https://doi.org/10.1089/dna.2022.0115
Abstract
Together with an anti-tumor immune response, oncolysis using a recombinant viral vector promises to eliminate cancer cells by both gene transfer and host-mediated functions. In this study we explore oncolysis induced by nonreplicating adenoviral vectors used for p14ARF and interferon-β (hIFNβ) gene transfer in human melanoma cell lines, revealing an unexpected role for p14ARF in promoting cellular responses predictive of immune stimulation. Oncolysis was confirmed when UACC-62 (p53 wild-type) cells succumbed upon p14ARF gene transfer in vitro, whereas SK-Mel-29 (p53-mutant) benefitted from its combination with hIFNβ. In the case of UACC-62, in situ gene therapy in nude mice yielded reduced tumor progression in response to the p14ARF and hIFNβ combination. Potential for immune stimulation was revealed where p14ARF gene transfer in vitro was sufficient to induce emission of immunogenic cell death factors in UACC-62 and upregulate pro-immune genes, including IRF1, IRF7, IRF9, ISG15, TAP-1, and B2M. In SK-Mel-29, p14ARF gene transfer induced a subset of these factors. hIFNβ was, as expected, sufficient to induce these immune-stimulating genes in both cell lines. This work is a significant advancement for our melanoma gene therapy strategy because we revealed not only the induction of oncolysis, but also the potential contribution of p14ARF to immune stimulation.Keywords
This publication has 34 references indexed in Scilit:
- Vaccination using melanoma cells treated with p19arf and interferon beta gene transfer in a mouse model: a novel combination for cancer immunotherapyCancer Immunology, Immunotherapy, 2016
- Preclinical safety and activity of recombinant VSV‐IFN‐β in an immunocompetent model of squamous cell carcinoma of the head and neckHead & Neck, 2013
- Combined p19Arf and interferon-beta gene transfer enhances cell death of B16 melanoma in vitro and in vivoCancer Gene Therapy, 2013
- Antisense gapmers selectively suppress individual oncogenic p73 splice isoforms and inhibit tumor growth in vivoMolecular Cancer, 2009
- A rapid and efficient method for purification of recombinant adenovirus with arginine–glycine–aspartic acid-modified fibersAnalytical Biochemistry, 2006
- TP53 mutations in human skin cancersHuman Mutation, 2003
- Human and Mouse IFN-β Gene Therapy Exhibits Different Anti-tumor Mechanisms in Mouse ModelsMolecular Therapy, 2001
- A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knobGene Therapy, 2001
- Mutation and expression of the p53 gene in human malignant melanomaMelanoma Research, 1994
- Determination of subcutaneous tumor size in athymic (nude) miceCancer Chemotherapy and Pharmacology, 1989